Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3 <i>H</i> )-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway

Prashant R. Murumkar, Kaushik Neogi, Premlal Meher, Rasana Yadav, Karan Joshi, Omkumar Prajapati, Priyanshu Sharma, Poonam Yadav, Devarajan Karunagaran, Prasanta Kumar Nayak, Mange Ram Yadav

Open source

DOI: 10.1080/17568919.2026.2714576
Published: 2026-08-17
Container: Future Medicinal Chemistry
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/17568919.2026.2714576,
  title = {Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3
                    <i>H</i>
                    )-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway},
  author = {Prashant R. Murumkar and Kaushik Neogi and Premlal Meher and Rasana Yadav and Karan Joshi and Omkumar Prajapati and Priyanshu Sharma and Poonam Yadav and Devarajan Karunagaran and Prasanta Kumar Nayak and Mange Ram Yadav},
  year = {2026},
  journal = {Future Medicinal Chemistry},
  doi = {10.1080/17568919.2026.2714576},
  url = {https://doi.org/10.1080/17568919.2026.2714576}
}

RIS

TY  - JOUR
TI  - Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3
                    <i>H</i>
                    )-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway
AU  - Prashant R. Murumkar
AU  - Kaushik Neogi
AU  - Premlal Meher
AU  - Rasana Yadav
AU  - Karan Joshi
AU  - Omkumar Prajapati
AU  - Priyanshu Sharma
AU  - Poonam Yadav
AU  - Devarajan Karunagaran
AU  - Prasanta Kumar Nayak
AU  - Mange Ram Yadav
PY  - 2026
JO  - Future Medicinal Chemistry
DO  - 10.1080/17568919.2026.2714576
UR  - https://doi.org/10.1080/17568919.2026.2714576
ER  -

APA

Murumkar, P. R., Neogi, K., Meher, P., Yadav, R., Joshi, K., Prajapati, O., Sharma, P., Yadav, P., Karunagaran, D., Nayak, P. K., & Yadav, M. R. (2026). Design and development of 2,7-disubstituted 6-methoxyquinazolin-4 (3 <i>H</i> )-ones as potential anti-cancer agents possibly through downregulation of Wnt/β-catenin/TCF4 signaling pathway. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2714576

Source records

crossref · retrieved 2026-09-27T13:21:04.148Z